Unity Bio Cuts 30% of Staff, Restructures to Focus on Ophthalmology and Neurology

UNITY Biotechnology launched a restructuring program to focus on cellular senescence in ophthalmology and neurology. As part of the plan, it is decreasing its workforce by about 30% to optimize capital.